TE
AXSM icon

Tema ETFs’s Axsome Therapeutics AXSM Stock Holding History

Tema ETFs’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,327
Closed -$243K – 515
2025
Q2 		$243K Hold
2,327
– – 0.06% 157
2025
Q1 		$271K Buy
+2,327
New +$265K 0.08% 133

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tema ETFs's AXSM Position: Q3 2025 in Review

Tema ETFs sold out of Axsome Therapeutics (AXSM) in Q3 2025, closing a stake of 2,327 shares — an estimated $243K sold.

Tema ETFs first reported a position in AXSM in Q1 2025 and held it in 2 quarters. The position peaked at $271K in Q1 2025. 355 funds tracked by Wall St. Rank hold AXSM as of Q3 2025.

  • Tema ETFs reported no remaining Axsome Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Tema ETFs sold 2,327 Axsome Therapeutics shares in Q3 2025, an estimated $243K.
  • Tema ETFs first reported a position in Axsome Therapeutics in Q1 2025 and held it in 2 quarters.
  • Tema ETFs's Axsome Therapeutics position peaked at $271K in Q1 2025.
  • 355 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2025.

Based on Tema ETFs's 13F filing for Q3 2025, filed 24 Oct 2025.